Who Exports Iodex from India — 140 Suppliers Behind a $6.6M Market

Hyderabad, often referred to as the "Pharma City of India," is a pivotal hub for bulk drug production. The city contributes approximately 40% of India's bulk drug output, earning it the title of the "Bulk Drug Capital of India." This prominence is bolstered by the presence of Genome Valley, a premier biotech cluster housing over 200 life sciences companies, including global giants like Novartis, Bayer, and Sanofi. The Telangana government's supportive policies, such as the Hyderabad Pharma City project, further enhance the region's appeal for pharmaceutical manufacturing.

The Ahmedabad-Vadodara corridor in Gujarat is renowned for its focus on pharmaceutical formulations. Gujarat accounts for 33% of India's drug manufacturing and 28% of drug exports, with Ahmedabad and Vadodara being central to this output. Vadodara, in particular, is home to Alembic Pharmaceuticals, one of India's oldest pharmaceutical companies, established in 1907. The region's robust infrastructure and concentration of both large and small pharma companies make it a significant player in the formulations sector.

The Mumbai-Thane-Raigad belt serves as a crucial export gateway for India's pharmaceutical industry. Mumbai, being a major port city, facilitates substantial pharmaceutical exports. The region hosts numerous pharmaceutical companies, leveraging its strategic location and well-established logistics network to access international markets efficiently.

Baddi-Nalagarh in Himachal Pradesh has emerged as a prominent pharmaceutical manufacturing zone, primarily due to favorable tax incentives. The region offers excise duty exemptions and income tax benefits, attracting numerous pharmaceutical companies to set up manufacturing units. This has led to significant growth in production capacity and cost advantages for companies operating in this cluster.

• Diversify Supplier Base: Given the concentration of Iodex exports among a few suppliers, expanding the supplier network within these clusters can mitigate risks associated with over-reliance on a limited number of sources.

• Leverage Regional Specializations: Utilize Hyderabad's bulk drug capabilities for raw materials and Gujarat's expertise in formulations to optimize the production process of Iodex.

• Optimize Logistics: Capitalize on the Mumbai-Thane-Raigad region's export infrastructure to streamline international distribution channels for Iodex.

• Explore Cost Benefits: Consider establishing manufacturing units in tax incentive zones like Baddi-Nalagarh to reduce production costs and enhance competitiveness in the market.